For citations:
Pchelintseva A.O., Zhornyak A.P., Ionichenok N.G., Panasyuk E.Yu., Ilyina A.E., Andrianova I.A., Gubar E.E., Tsvetkova E.S., Cherkasova M.V., Aleksandrova E.N., Denisov L.N., Nasonov E.L. CHANGES IN CALPROTECTIN LEVEL, ITS RELATIONSHIP TO THE CLINICAL AND LABORATORY PARAMETERS OF DISEASE ACTIVITY AND SIGNIFICANCE FOR PREDICTING THE THERAPEUTIC RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT. Rheumatology Science and Practice. 2015;53(4):379-384. (In Russ.) https://doi.org/10.14412/1995-4484-2015-379-384
Email this article 